Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Operating Margin 2010-2025 | HYPMY

Current and historical operating margin for Hypermarcas (HYPMY) over the last 10 years. The current operating profit margin for Hypermarcas as of March 31, 2025 is 11.34%.
  
Hypermarcas Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $1.20B $0.18B 15.23%
2024-12-31 $1.38B $0.34B 24.51%
2024-09-30 $1.50B $0.44B 29.27%
2024-06-30 $1.60B $0.50B 31.45%
2024-03-31 $1.63B $0.52B 31.82%
2023-12-31 $1.59B $0.50B 31.78%
2023-09-30 $1.62B $0.53B 32.88%
2023-06-30 $1.57B $0.51B 32.65%
2023-03-31 $1.50B $0.50B 32.96%
2022-12-31 $1.46B $0.48B 32.99%
2022-09-30 $1.35B $0.45B 33.09%
2022-06-30 $1.27B $0.42B 33.02%
2022-03-31 $1.17B $0.40B 33.70%
2021-12-31 $1.10B $0.37B 33.27%
2021-09-30 $1.02B $0.33B 32.58%
2021-06-30 $0.91B $0.30B 32.42%
2021-03-31 $0.82B $0.27B 32.52%
2020-12-31 $0.79B $0.26B 32.24%
2020-09-30 $0.81B $0.24B 29.40%
2020-06-30 $0.87B $0.24B 27.63%
2020-03-31 $0.92B $0.23B 24.54%
2019-12-31 $0.84B $0.28B 32.93%
2019-09-30 $0.84B $0.31B 36.39%
2019-06-30 $0.83B $0.31B 36.88%
2019-03-31 $0.84B $0.33B 39.40%
2018-12-31 $1.02B $0.34B 32.97%
2018-09-30 $1.06B $0.34B 31.89%
2018-06-30 $1.12B $0.36B 31.94%
2018-03-31 $1.13B $0.36B 32.18%
2017-12-31 $1.14B $0.36B 31.93%
2017-09-30 $1.11B $0.36B 32.43%
2017-06-30 $1.06B $0.35B 32.80%
2017-03-31 $1.03B $0.34B 32.88%
2016-12-31 $0.94B $0.31B 32.56%
2016-09-30 $0.39B $0.28B 71.50%
2016-06-30 $0.52B $0.27B 52.60%
2016-03-31 $0.70B $0.24B 34.24%
2015-12-31 $0.90B $0.27B 29.90%
2015-09-30 $1.72B $0.29B 17.08%
2015-06-30 $1.82B $0.29B 15.81%
2015-03-31 $1.92B $0.35B 18.17%
2014-12-31 $1.97B $0.36B 18.30%
2014-09-30 $1.96B $0.41B 20.78%
2014-06-30 $1.99B $0.46B 23.24%
2014-03-31 $1.95B $0.41B 21.01%
2013-12-31 $1.95B $0.39B 19.73%
2013-09-30 $1.98B $0.41B 20.53%
2013-06-30 $1.97B $0.39B 19.92%
2013-03-31 $1.98B $0.42B 21.27%
2012-12-31 $1.96B $0.36B 18.51%
2012-09-30 $1.78B $0.29B 16.23%
2012-06-30 $1.84B $0.22B 11.88%
2012-03-31 $1.96B $0.21B 10.48%
2011-12-31 $2.00B $0.25B 12.66%
2011-09-30 $2.21B $0.29B 13.16%
2011-06-30 $2.12B $0.35B 16.29%
2011-03-31 $1.96B $0.33B 16.74%
2010-12-31 $1.81B $0.32B 17.49%
2010-09-30 $1.65B $0.26B 15.62%
2010-06-30 $1.44B $0.24B 16.53%
2010-03-31 $1.22B $0.24B 19.22%
2009-12-31 $1.03B $0.20B 19.24%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.725B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $67.532B 25.98
Zoetis (ZTS) United States $66.043B 23.96
Daiichi Sankyo, - (DSNKY) Japan $46.279B 23.72
Takeda Pharmaceutical (TAK) Japan $45.915B 9.37
BeOne Medicines - (ONC) Switzerland $31.757B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.520B 0.00
Summit Therapeutics (SMMT) United States $20.980B 0.00
Merck (MKKGY) Germany $16.285B 10.59
Shionogi (SGIOY) Japan $15.227B 15.26
United Therapeutics (UTHR) United States $13.551B 11.73
Neurocrine Biosciences (NBIX) United States $12.297B 36.68
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.413B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.760B 0.00
Corcept Therapeutics (CORT) United States $7.584B 63.69
Grifols, S.A (GRFS) Spain $7.288B 0.00
Stevanato Group S.p.A (STVN) Italy $6.617B 39.02
Ionis Pharmaceuticals (IONS) United States $6.510B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.558B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.771B 13.19
NewAmsterdam Pharma (NAMS) Netherlands $2.736B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.579B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.409B 8.07
Centessa Pharmaceuticals (CNTA) United Kingdom $2.219B 0.00
Ocular Therapeutix (OCUL) United States $2.185B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.721B 0.00
ARS Pharmaceuticals (SPRY) United States $1.609B 0.00
Dyne Therapeutics (DYN) United States $1.599B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.505B 22.41
Evotec AG (EVO) Germany $1.353B 0.00
Ardelyx (ARDX) United States $1.301B 0.00
Guardian Pharmacy Services (GRDN) United States $1.258B 0.00
Harrow (HROW) United States $1.238B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.237B 0.00
Xeris Biopharma Holdings (XERS) United States $1.163B 0.00
Collegium Pharmaceutical (COLL) United States $1.138B 6.22
Cronos Group (CRON) Canada $1.025B 0.00
Enliven Therapeutics (ELVN) United States $0.889B 0.00
Akebia Therapeutics (AKBA) United States $0.888B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.697B 0.00
Siga Technologies (SIGA) United States $0.679B 8.39
ProKidney (PROK) United States $0.660B 0.00
Zevra Therapeutics (ZVRA) United States $0.640B 0.00
KalVista Pharmaceuticals (KALV) United States $0.625B 0.00
Elite Pharmaceuticals (ELTP) United States $0.610B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.600B 6.18
Organogenesis (ORGO) United States $0.585B 0.00
Theravance Biopharma (TBPH) United States $0.570B 0.00
Bioventus (BVS) United States $0.569B 13.86
Relay Therapeutics (RLAY) United States $0.560B 0.00
Tourmaline Bio (TRML) United States $0.539B 0.00
USANA Health Sciences (USNA) United States $0.536B 10.98
Xencor (XNCR) United States $0.499B 0.00
Oruka Therapeutics (ORKA) United States $0.489B 0.00
Savara (SVRA) United States $0.467B 0.00
Aquestive Therapeutics (AQST) United States $0.383B 0.00
Esperion Therapeutics (ESPR) United States $0.366B 0.00
Nanobiotix S.A (NBTX) France $0.352B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.331B 0.00
Aldeyra Therapeutics (ALDX) United States $0.314B 0.00
AleAnna (ANNA) United States $0.313B 0.00
Larimar Therapeutics (LRMR) United States $0.313B 0.00
Nature's Sunshine Products (NATR) United States $0.284B 18.51
Nektar Therapeutics (NKTR) United States $0.279B 0.00
Altimmune (ALT) United States $0.274B 0.00
4D Molecular Therapeutics (FDMT) United States $0.256B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
OmniAb (OABI) United States $0.239B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Heron Therapeutics (HRTX) United States $0.196B 0.00
China SXT Pharmaceuticals (SXTC) China $0.184B 0.00
Journey Medical (DERM) United States $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.178B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Profound Medical (PROF) Canada $0.169B 0.00
Lyell Immunopharma (LYEL) United States $0.164B 0.00
MEI Pharma (MEIP) United States $0.156B 0.00
Lexeo Therapeutics (LXEO) United States $0.147B 0.00
Korro Bio (KRRO) United States $0.141B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.135B 20.91
Avita Medical (RCEL) United States $0.128B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Avalo Therapeutics (AVTX) United States $0.118B 0.00
Liminatus Pharma (LIMN) United States $0.117B 0.00
Inhibikase Therapeutics (IKT) United States $0.112B 0.00
Cassava Sciences (SAVA) United States $0.109B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.088B 19.94
Surrozen (SRZN) United States $0.086B 0.00
Cardiol Therapeutics (CRDL) Canada $0.085B 0.00
Achieve Life Sciences (ACHV) Canada $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.085B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
BioNxt Solutions (BNXTF) Canada $0.080B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
Nutriband (NTRB) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Metagenomi (MGX) United States $0.068B 0.00
Pyxis Oncology (PYXS) United States $0.064B 0.00
Inotiv (NOTV) United States $0.064B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.062B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
DURECT (DRRX) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.057B 0.00
Wellgistics Health (WGRX) United States $0.056B 0.00
PolyPid (PYPD) Israel $0.051B 0.00
Unicycive Therapeutics (UNCY) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.042B 25.82
Plus Therapeutics (PSTV) United States $0.042B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.038B 0.00
Enlivex Therapeutics (ENLV) Israel $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
FibroGen (FGEN) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Karyopharm Therapeutics (KPTI) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Tempest Therapeutics (TPST) United States $0.030B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Mural Oncology (MURA) Ireland $0.027B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Cosmos Health (COSM) United States $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.021B 0.00
CASI Pharmaceuticals (CASI) China $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.019B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Ainos (AIMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
BioVie (BIVI) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.52
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00